Cimzia (Certolizumab) Infusions

Cimzia belongs to a class of drugs known as tumor necrosis factor (TNF) blockers. It works by blocking TNF, a substance made by the body that causes inflammation. Generically known as certolizumab, Cimzia infusions are used to treat the symptoms of Crohn’s disease after other treatments have failed.

Cimzia infusions and certolizumab injectable therapies are also used to treat rheumatoid arthritis and psoriatic arthritis, as well as:

  • Ankylosing spondylitis

  • Plaque psoriasis

  • Non-radiographic axial spondylarthritis.

Drug manufacturer information for Cimzia is available here.

Indication:

  • Chron’s disease

  • Rheumatoid Arthritis

  • Psoriatic arthritis

  • Ankylosing Spondylitis

  • Plaque Psoriasis

  • Non-Radiographic Axial Spondylarthritis

Cimzia Infusion Duration:

Frequency:

  • Loading Dose: 2 injections, received over 4 weeks at 2-week intervals

  • Maintenance Dose: Every 4-weeks